Targeted nanomedicine holds promise to find clinical use in many medical areas.
Endothelial cells that line the luminal surface of blood vessels represent a key target for …

Particles capable of homing and adhering to specific vascular biomarkers have potential as
fundamental tools in drug delivery for mediation of a wide variety of pathologies, including …

Endothelium, a thin monolayer of specialized cells lining the lumen of blood vessels is the
key regulatory interface between blood and tissues. Endothelial abnormalities are …

The bloodstream is the main transporting pathway for drug delivery systems (DDS) from the
site of administration to the intended site of action. In many cases, components of the …

Vascular‐targeted nanocarriers are an attractive option for the treatment of a number of
cardiovascular diseases, as they allow for more specific delivery and increased efficacy of …

A computational methodology based on Metropolis Monte Carlo (MC) and the weighted
histogram analysis method (WHAM) has been developed to calculate the absolute binding …

Nanomedicine approaches have revolutionized the treatment of cancer and vascular
diseases, where the limitations of rapid nonspecific clearance, poor biodistribution and …

This review seeks to highlight the enormous potential of targeted nanoparticles for molecular
imaging applications. Being the closest point-of-contact, circulating nanoparticles can gain …

Vascular-targeted drug delivery systems could provide more efficient and effective
pharmaceutical interventions for treating a variety of diseases including cardiovascular …

Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …